rabies vaccine

The rabies vaccine is Hohsalle’s experimental preventive treatment for people bitten by rabid animals: an injected, weakened form of the disease agent intended to prepare the body to fight infection before rabies develops. Its importance lies not in a guaranteed cure, but in the possibility of acting during the narrow interval before a disease that is fatal once symptoms appear—and in the uncertainty that accompanies a treatment Hohsalle has used in only a small number of cases.

Purpose and Administration

Hohsalle explains the treatment after Governor Ohan asks about medicine to protect people who have been bitten. It is not swallowed: a needle is used to inject it several times, with a few days between injections. Its purpose is preventive, rather than a remedy for established rabies. Hohsalle says that once the disease manifests, nothing can be done and death is inevitable, so the injections are offered as a chance to intervene before symptoms begin.

The weakened agent is meant to help the body resist the disease, but Hohsalle does not present it as risk-free or certain to work. When Utalu objects that the preparation is still the same disease, Hohsalle acknowledges that, in a simplified sense, it is. The method is new, with few cases of use, and its risks are not yet fully known. His evidence at that point is that twelve people have survived without exhibiting symptoms; he later confirms that the dog that bit them died of rabies, countering Utalu’s suggestion that they might never have been infected.

How the Treatment Works

To explain the treatment, Hohsalle compares the body’s defenses to soldiers guarding a fortress. The metaphor makes an invisible process intelligible: the body contains many kinds of defenders, each with different tasks, and disease agents can be difficult to identify on first encounter. Pus, he explains, consists of the bodies of invisible soldiers killed while consuming agents that entered a wound. Their struggle can end with a scab and new skin, an outward sign of the body having overcome an infection.

A weakened agent acts as a lesson for those defenses. It introduces a damaged, weakened version of the disease so the body’s defenders can learn to recognize the enemy and respond to it. Hohsalle traces the underlying insight to his grandfather, Limuelle, who worked out why people sometimes contract certain diseases only once and conceived the idea of introducing weakened agents into the body. Hohsalle says that he built on Limuelle’s discovery and developed a medicine that could be injected. The process still taxes the body because it introduces a foreign substance; the preparation’s protective purpose does not remove that burden.

Evidence, Uncertainty, and Risk

The record of twelve recipients gives Hohsalle grounds to recommend the treatment, but not to claim certainty. Although none of those patients developed symptoms, the number is too small to establish that adverse outcomes are impossible. Hohsalle warns Yotalu that some patients could react violently and be left with severe mental impairment. He says this has not happened among the twelve he has treated, while stressing that the experience is insufficient to rule out the danger.

That uncertainty shapes the decisions around particular patients. When Yotalu asks that the treatment be given to Sulumina and Olimu, Hohsalle pauses rather than treating the request as a routine procedure. Limuelle proposes first obtaining Yotalu’s permission, noting that Sulumina is Governor Ohan’s younger son’s wife and Olimu his precious grandson; Sulumina agrees to the request for permission. The scene places the treatment between urgency and caution: possible protection against a fatal disease comes with an incompletely measured risk borne by the person receiving it.

Wider Use and Continuing Limits

The vaccine also becomes part of the response to a suspected rabies threat beyond individual cases. After hearing Hohsalle’s explanation, the King of Aquafa agrees to have those bitten observed and to administer the vaccine if considered necessary, then requests it for all Aquafaese. Hohsalle distinguishes rabies from black wolf fever: rabies is fearsome, but he says there is a possible way to suppress its symptoms and that it does not spread rapidly through ticks or other insects. He considers black wolf fever the greater threat.

The distinction matters because the vaccine is not presented as a solution to the larger epidemic problem. Hohsalle’s account of black wolf fever describes a separate effort to develop weakened agents, disease-suppressing drugs, and serum, while the rabies vaccine is a treatment he has already made injectable and used in twelve cases. Even here, its demonstrated history remains limited, and the text does not establish that the King’s broad request results in universal administration. Its significance is therefore both practical and provisional: it offers a way to act before rabies becomes untreatable, while leaving the decision bound to evidence, consent, and risk.